{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:41:22Z","timestamp":1789094482551,"version":"build-2803163510"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to evaluate the value of machine learning-based dynamic contrast-enhanced MRI (DCE-MRI) radiomics nomogram in prediction treatment response of neoadjuvant chemotherapy (NAC) in patients with osteosarcoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 102 patients with osteosarcoma and who underwent NAC were enrolled in this study. All patients received a DCE-MRI scan before NAC. The Response Evaluation Criteria in Solid Tumors was used as the standard to evaluate the NAC response with complete remission and partial remission in the effective group, stable disease, and progressive disease in the ineffective group. The following semi-quantitative parameters of DCE-MRI were calculated: early dynamic enhancement wash-in slope (Slope), time to peak (TTP), and enhancement rate (R). The acquired data is randomly divided into 70% for training and 30% for testing. Variance threshold, univariate feature selection, and least absolute shrinkage and selection operator were used to select the optimal features. Three classifiers (K-nearest neighbor, KNN; support vector machine, SVM; and logistic regression, LR) were implemented for model establishment. The performance of different classifiers and conventional semi-quantitative parameters was evaluated by confusion matrix and receiver operating characteristic curves. Furthermore, clinically relevant risk factors including age, tumor size and site, pathological fracture, and surgical staging were collected to evaluate their predictive values for the efficacy of NAC. The selected clinical features and imaging features were combined to establish the model and the nomogram, and then the predictive efficacy was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The clinical relevance risk factor analysis demonstrates that only surgical stage was an independent predictor of NAC. A total of seven radiomic features were selected, and three machine learning models (KNN, SVM, and LR) were established based on such features. The prediction accuracy (ACC) of these three models was 0.89, 0.84, and 0.84, respectively. The area under the subject curve (AUC) of these three models was 0.86, 0.92, and 0.93, respectively. As for Slope, TTP, and R parameters, the prediction ACC was 0.91, 0.89, and 0.81, respectively, while the AUC was 0.87, 0.85, and 0.83, respectively. In both the training and testing sets, the ACC and AUC of the combined model were higher than those of the radiomics models (ACC = 0.91 and AUC = 0.95), which indicate an outstanding performance of our proposed model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The radiomics nomogram demonstrates satisfactory predictive results for the treatment response of patients with osteosarcoma before NAC. This finding may provide a new decision basis to improve the treatment plan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2021.758921","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:13:42Z","timestamp":1636935222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy"],"prefix":"10.3389","volume":"11","author":[{"given":"Lu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuru","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","article-title":"Cancer Statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26349","article-title":"Perinatal Factors Associated With Clinical Presentation of Osteosarcoma in Children and Adolescents","volume":"64","author":"Endicott","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/14737140.2018.1413939","article-title":"Current and Future Therapeutic Approaches for Osteosarcoma","volume":"18","author":"Harrison","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy310","article-title":"Bone Sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jse.2016.01.020","article-title":"Quantitative Diffusion-Weighted Magnetic Resonance Imaging for the Diagnosis of Partial-Thickness Rotator Cuff Tears","volume":"25","author":"Lo","year":"2016","journal-title":"J Shoulder Elbow Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.lungcan.2017.10.015","article-title":"Radiomics and Radiogenomics in Lung Cancer: A Review for the Clinician","volume":"115","author":"Thawani","year":"2018","journal-title":"Lung Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1186\/s12885-017-3847-7","article-title":"Radiomics Based Analysis to Predict Local Control and Survival in Hepatocellular Carcinoma Patients Treated With Volumetric Modulated Arc Therapy","volume":"17","author":"Cozzi","year":"2017","journal-title":"BMC Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9128","article-title":"Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer","volume":"34","author":"Huang","year":"2016","journal-title":"Sci Foundation China"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13569-016-0047-1","article-title":"UK Guidelines for the Management of Bone Sarcomas","volume":"6","author":"Gerrand","year":"2016","journal-title":"Clin Sarcoma Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New Response Evaluation Criteria in Solid Tumours: Revised RECIST Guideline (Version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-5898(20)32093-9","article-title":"The Staging and Surgery of Musculoskeletal Neoplasms","volume":"27","author":"Wolf","year":"1996","journal-title":"Orthop Clin North Am"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy310","article-title":"Bone Sarcomas: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"25","author":"Casali","year":"2014","journal-title":"Ann Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2017.05.071","article-title":"Beyond Imaging: The Promise of Radiomics","volume":"38","author":"Avanzo","year":"2017","journal-title":"Physica Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.2631","article-title":"The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review","volume":"2","author":"Aerts","year":"2016","journal-title":"JAMA Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: Images Are More Than Pictures, They Are Data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"B16","first-page":"1181","article-title":"Clinical Evaluation of Neoadjuvant Chemotherapy for Osteosarcoma","volume":"24","author":"Zhu","year":"2019","journal-title":"J B.U.ON. Off J Balkan Union Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.3390\/jcm9124070","article-title":"Radiological Assessment and Outcome of Local Disease Progression After Neoadjuvant Chemotherapy in Children and Adolescents With Localized Osteosarcoma","volume":"9","author":"Fonseca","year":"2020","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jmri.26589","article-title":"T2 -Based MRI Delta-Radiomics Improve Response Prediction in Soft-Tissue Sarcomas Treated by Neoadjuvant Chemotherapy","volume":"50","author":"Cromb\u00e9","year":"2019","journal-title":"J Magnetic Resonance Imaging JMRI"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0702","article-title":"Large-Scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response","volume":"22","author":"Kickingereder","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213459","article-title":"Gray-Level Discretization Impacts Reproducible MRI Radiomics Texture Features","volume":"14","author":"Duron","year":"2019","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmri.25939","article-title":"Differentiation Between Vasogenic Edema and Infiltrative Tumor in Patients With High-Grade Gliomas Using Texture Patch-Based Analysis","volume":"3","author":"Artzi","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1109\/TBME.2015.2395812","article-title":"Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for Classifying Breast Cancer Recurrence Risk","volume":"62","author":"Mahrooghy","year":"2015","journal-title":"IEEE Trans Biomed Eng"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00980","article-title":"Radiomics Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Sentinel Lymph Node Metastasis in Breast Cancer","volume":"9","author":"Liu","year":"2019","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-020-02109-0","article-title":"Cardiac SPECT Radiomic Features Repeatability and Reproducibility: A Multi-Scanner Phantom Study","author":"Edalat-Javid","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.24879","article-title":"Computational Approach to Radiogenomics of Breast Cancer: Luminal A and Luminal B Molecular Subtypes Are Associated With Imaging Features on Routine Breast MRI Extracted Using Computer Vision Algorithms","volume":"42","author":"Grimm","year":"2015","journal-title":"J Magnetic Resonance Imaging"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.758921\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:13:49Z","timestamp":1636935229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.758921\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":25,"alternative-id":["10.3389\/fonc.2021.758921"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.758921","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"article-number":"758921"}}